Morgan Stanley analyst Thibault Boutherin downgraded Novo Nordisk (NOVOB:DC) (NYSE: NVO) from Equalweight to Underweight with a price target of ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments Downgrades Intl Ratings